K-numberK253953
Device nameIPS e.max Zirconia
ApplicantIvoclar Vivadent, Inc.
Product codeEIH
Device classClass II
Decision dateMar 10, 2026
DecisionSubstantially Equivalent
Regulation872.6660
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

IPS e.max Zirconia is a yttrium-stabilized zirconium oxide material used to fabricate fixed all-ceramic dental restorations such as crowns, bridges, inlays, onlays, and veneers. The material is supplied as pre-sintered discs with incisal, transition, and dentin zones in various shades and thicknesses, plus accompanying color and effect liquids for staining and characterization before final sintering.

Technological characteristics

IPS e.max Zirconia features zoned disc design (incisal, transition, dentin zones) with different strength properties to enable more esthetic restorations compared to the single-shaded predicate discs. More conservative design parameters were established for the new device. Chemical composition is similar to the predicate but in different quantities. Chemical solubility is 10 µg·cm⁻² (vs. 100 µg·cm⁻² for predicate) due to different ISO 6872 versions; linear thermal expansion is slightly lower but conforms to ISO 6872:2024.

Test standards cited

EN ISO 6872:2024 (Dentistry – Ceramic Materials); ISO 10993 (biocompatibility); ISO 7405; ISO 21726:2019; ISO 14971:2019. Device classified as Type II Class 5 under ISO 6872:2024.

Substantial equivalence argument

Both devices are pre-sintered zirconia discs for fabricating fixed all-ceramic dental restorations via CAD/CAM milling followed by sintering. Although IPS e.max Zirconia supports additional indications (inlays and veneers) and has zoned disc design, these are common features for this device type. Biocompatibility was fully assessed and found substantially equivalent; device performance testing met ISO 6872 criteria. The working principle, material composition, and clinical application are substantially equivalent to the predicate Zenostar devices.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →